Acute Porphyria Drug Database

Monograph

M01AE52 - Naproxen and Esomeprazole
Propably not porphyrinogenic
PNP

Rationale
This combination product contains two substances: naproxen (ATC code: M01A E02) and esomeprazole (ATC code: A02B C05). Both of them are safety classified as Probably not porphyrinogenic* (PNP*). The classification of this combination is therefore safety classified as Probably not porphyrinogenic. For more details please refer to the monographs of the two substances.

Similar drugs
Explore alternative drugs in similar therapeutic classes M01A / M01AE or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Vimovo · Vimovo 500 mg/20 mg tabletten met gereguleerde afgifte · Vimovo 500 mg/20 mg, tabletten met gereguleerde afgifte
Belgium
Vimovo · Vimovo 500 mg - 20 mg compr. lib. modif.
United Kingdom
Naproxen / Esomeprazole · Naproxen 500mg / Esomeprazole 20mg modified-release tablets · Vimovo · Vimovo 500mg/20mg modified-release tablets
Denmark
Emoxenduo
Norway
Vimovo
Poland
Emoxen
Luxembourg
Vimovo
Finland
Emoxenduo · Vamtexar · Vimovo
Latvia
Esmapren
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙